Monographs
The ISHLT Monograph Series is an hardcover publication of the Society that provides in-depth coverage of the current state of knowledge of a specific topic relevant to heart and lung transplantation and/or end stage heart and lung disease.
Hardback copies of ISHLT Monographs can be purchased directly from ISHLT, or certain volumes can also be purchased as eBooks from your favorite online retailers.
Published 1 January 2009
Editors:
Order NowJames K. Kirklin, MD
Nicholas Banner, FRCP, FESC
Mariell Jessup, MD, FAHA, FACC, FESC
Members - $50.00 | Non-Members - $90.00
SECTION I: Introduction
Chapter 1: Introduction
Mariell Jessup
SECTION II: Pathophysiology of the Failing Heart
Chapter 2: Cellular and Subcellular Abnormalities
Risto Kerkelö and Thomas Force
Chapter 3: The Cardiac Interstitium
Ahmad Munir, Richard C. Davis, and Karl T. Weber
Chapter 4: Ventricular Remodeling in Advanced Heart Failure
John Harding and Thomas P. Cappola
Chapter 5:
Neurohormones and Cytokines in Heart Failure
James O. Mudd and Stuart D. Russell
Chapter 6: Exercise Intolerance in Heart Failure
Finn Gustafsson and Heather J. Ross
SECTION III: Cardiac Evaluation in the Patient with Advanced Heart Failure
Chapter 7: Clinical Assessment of Hemodynamic Status in Advanced Heart Failure
Lynne Warner Stevenson
Chapter 8: The Evolving Role for Hemodynamic Analysis in Heart Failure
David A. Kass
Chapter
9: The Role of Cardiac Catheterization in Patients Who have Advanced Heart Failure
Robert L. Wilensky and Ruchira Glaser
Chapter 10: Echocardiography
James N. Kirkpatrick
Chapter 11:
Nuclear and Positron Emission Tomography Imaging
Danilo Neglia and Alessia Gimelli
Chapter 12: Cardiovascular Magnetic Resonance
R. O'Hanlon and D.J. Pennell
Chapter 13: Computed Tomography
Edward D. Nicol, James E. Stirrup, and Michael B. Rubens
Chapter 14: The Role of ndomyocardial Biopsy in Advanced Heart Failure
Leslie T. Cooper, Jr.
Chapter 15: B-Type Natriuretic Peptide and
Other Natriuretic Factors
Roy S. Gardner and Theresa A. McDonagh
Chapter 16: Troponin and Other Biomarkers
Thomas J. Dengler, Evangelos Giannitsis and Hugo A. Katus
Chapter 17: Biomarkers and
Other Prognostic Schemas in Heart Failure
Wayne C. Levy
Chapter 18: Cardiopulmonary Exercise Testing in Advanced Heart Failure
Santiago Miriuka and Heather J. Ross
SECTION IV: Secondary Organ Dysfunction in Heart Failure
Chapter 19: The Cardiorenal Syndrome: Pathophysiology and Management
Michael R. Smith, Jie Li, Jigar Patel, and J. Thomas Heywood
Chapter 20: The Liver in Heart Failure
Arie J. Stangou and Nicholas R. BannerChapter 21: Cognitive Dysfunction in Patients with Chronic Heart Failure
Elaine M. Winkel, Walter G. Kao, Brian D. Juncker, and Maryl R. Johnson
Chapter 22: Skeletal Muscle Dysfunction and Deconditioning
in Heart Failure
Donna M. Mancini and Chim C. Lang
SECTION V: Stabilization of the Heart Failure Syndrome: First Steps and Initiating Maintenance
Chapter 23: Diuretics: Utility and Limitations
David S. Feldman, Terry S. Elton, and Kerry Pickworth
Chapter 24: Renin-Antiotensin-Aldosterone Antagonists: When, How Much, and Limiting Factors
Michael B.
Fowler
Chapter 25: ß-Blockers in Heart Failure: When to Start and When to Stop
Simon F. Shakar and JoAnn Lindenfeld
Chapter 26: Vasodilator Therapy in Advanced Heart Failure
Jennifer
R. Brown, Patricia A. Uber, and Mandeep R. Mehra
Chapter 27: Intravenous Inotropic Agents
Haifa Lyster and Nicholas R. Banner
Chapter 28: Anticoagulation and Antiplatelet Therapy in the Patient with
Advanced Heart Failure in Sinus Rhythm
Liviu Klein and John B. O'Connell
SECTION VI: Arrhythmias and Electrical Devices in the Patient with Advanced Heart Failure
Chapter 29: Atrial Fibrillation
David G. Jones and Vias Markides
Chapter 30: Cardiac Resynchronization Therapy
Zachary I. Whinnett, Darrel P. Francis, Jamil Mayet, and Nicholas S. Peters
Chapter 31: Implantable Cardioverter-Defibrillator Devices
E. Gronda, D. Pini and A. Municinò
Chapter 32: Management
of Recurrent Ventricular Arrhythmia
Matthew Wright, Ian Wright, and D. Wyn Davies
Chapter 33: Emergency Pacemakers in Advanced Heart Failure
Ralph J. Verdino
SECTION VII: Clinicopathological Correlations
Chapter 34: Acute Myocarditis: Diagnosis and Treatment
G. William Dec
Chapter 35: Giant Cell Myocarditis
Margaret M. Burke and Andrew G. Mitchell
Chapter 36: Amyloid Heart Disease
S.W. Dubrey and R.H. Falk
Chapter 37: Pericardial Disorders
Zuheir Abrahams, Hadi N. Skourie, Wilfried Mullens, Mohammad H. Yamani, and Randall C. Starling
SECTION VIII: Shock Complicating the Acute Coronary Syndrome
Chapter 38: Reperfusion and Failure of Reperfusion
H.S. Lim and J.N. Townend
Chapter 39: Myocardial Stunning
Rainer Zbinden and Michael Marber
Chapter 40: Mitral Regurgitation and Ventricular Septal Rupture After Myocardial Infarction
J.R. Pepper
Chapter 41: Shock Due to Catastrophic Loss of Myocardium
Stephen S. L. Tsui and Jayan Parameshwar
SECTION IX: Surgical Reparative Therapy
Chapter 42: Myocardial Revascularization for Heart Failure
J. Thekkudan, V.B. Dronavalli and R.S. Bonser
Chapter 43: Mitral Valve Regurgitation
G.D. Dreyfus
Chapter 44: Reverse Remodeling Procedures: Surgical Ventricular Restoration and Prosthetic Girdling Devices
Aaron S. Blom and Michael A. Acker
SECTION X: Other Therapies
Chapter 45: Intra-Aortic Balloon and Other Counterpulsation Techniques
Alistair C. Lindsay, Asghar Khaghani, and Miles C.D. Dalby
Chapter 46: Transplantation
Sharon A. Hunt
Chapter 47: Permanent Ventricular Assist Devices
Saba N. Khan and Marc A. Silver
Chapter 48: When Is Myocardial Failure Reversible
Nicholas R. Banner
SECTION XI: Supportive Care at End of Life
Chapter 49: Supportive and End-of-Life Care
Dale G. Renlund, Sally J. Brush, Kismet D. Rasmusson, and Abdallah G. Kfoury
SECTION XII: New Horizons
Chapter 50: New Horizons in the Treatment of Heart Failure
Kumudha Ramasubbu and Douglas L. Mann